LIVER-TRANSPLANTATION ACROSS ABO BLOOD-GROUP BARRIERS

被引:252
作者
GUGENHEIM, J
SAMUEL, D
REYNES, M
BISMUTH, H
机构
[1] HOP PAUL BROUSSE,S PARIS FAC MED,HEPATOBILIARY SURG & TRANSPLANTAT RES UNIT,F-94800 VILLEJUIF,FRANCE
[2] HOP PAUL BROUSSE,S PARIS FAC MED,DEPT PATHOL,F-94800 VILLEJUIF,FRANCE
关键词
D O I
10.1016/0140-6736(90)92082-S
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a study of 234 liver transplants the 2-year graft survival for ABO-compatible elective (80%) or emergency (76%) liver transplants was significantly higher than that for ABO-incompatible emergency liver transplants (30%). The low survival of ABO-incompatible liver allografts was therefore not related to the emergency conditions. Among 17 patients who received ABO-incompatible liver allografts, primary humoral rejection, with haemorrhagic infiltration of portal tracts and deposition of IgM and fibrinogen on sinusoidal and endothelial cells, developed in 6. Other disadvantages of ABO-incompatible liver allografts were significantly higher frequencies of severe rejection crises, arterial thrombosis, and cholangitis. However, the 1-year survival rate of the patients who received ABO-incompatible grafts was 66%, so the use of ABO-incompatible liver grafts is justifiable in emergencies, when no other donor is available; such transplants may help to save the patient, even at the cost of retransplantation in half of the cases. © 1990.
引用
收藏
页码:519 / 523
页数:5
相关论文
共 17 条
[11]  
MARSH JW, 1988, ANN SURG, V207, P21
[12]  
ROUGER P, 1986, TISSUE ANTIGENS, V27, P78
[13]  
SAMUEL D, 1989, TRANSPLANT P, V21, P2225
[14]  
STARZL TE, 1974, TRANSPLANT P, V6, P129
[15]   SHWARTZMAN REACTION AFTER HUMAN RENAL HOMOTRANSPLANTATION [J].
STARZL, TE ;
LERNER, RA ;
DIXON, FJ ;
GROTH, CG ;
BRETTSCHNEIDER, L ;
TERASAKI, PI .
NEW ENGLAND JOURNAL OF MEDICINE, 1968, 278 (12) :642-+
[16]  
VALDIVIA LA, 1987, TRANSPL P, V19, P1158
[17]  
WEIL R, 1981, TRANSPLANTATION, V32, P71